Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
-19.49
↓ 102% below average
Average (9y)
1152.29
Historical baseline
Range
High:7219.85
Low:-19.49
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -19.49 | -110.7% |
| 2023 | 182.21 | +422.3% |
| 2022 | 34.88 | -99.5% |
| 2021 | 7219.85 | +208.4% |
| 2020 | 2340.92 | +92.0% |
| 2019 | 1218.99 | +742.7% |
| 2018 | 144.65 | +51.6% |
| 2017 | 95.43 | -44.3% |
| 2016 | 171.37 | +27.8% |
| 2015 | 134.13 | - |